Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.53 |
| ▸ | PPARD | Q03181 | 5/20 | 0.53 |
| ▸ | PPARA | Q07869 | 5/20 | 0.53 |
| ▸ | F7 | P08709 | 4/20 | 0.53 |
| ▸ | F3 | P13726 | 4/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | FABP4 | P15090 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.53 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.53 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271901 | 1.00 | PPARG (0.53) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL1470099 | 1.00 | PPARG (0.53) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL1273217 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL5490197 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL45203 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL30413 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL253962 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL5495040 | 0.91 | GPR84 (0.44) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL5395520 | 0.89 | AKR1B1 (0.42) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL786356 | 0.84 | EPHX2 (0.47) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2062 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4398882-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2024-07-17 | — | — | EP | claimed |
| US-20240226325-A1 | CATIONIC LIPIDS AND COMPOSITIONS THEREOF | GENERATION BIO CO. | 2024-07-11 | — | — | US | claimed |
| EP-4382094-A1 | ATHEROSCLEROSIS-TARGETED LIPOSOME NANOCARRIER DELIVERY SYSTEM AND PREPARATION METHOD THEREFOR | Beijing Inno Medicine Co., Ltd. (CN) | 2024-06-12 | — | — | EP | claimed |
| WO-2024119017-A1 | SYNTHETIC SINGLE STRANDED NUCLEIC ACID COMPOSITIONS AND METHODS THEREOF | GENERATION BIO CO. (US) | 2024-06-06 | — | — | WO | claimed |
| US-20240180940-A1 | MPLA COMPOSITIONS AND METHODS OF USE | REVELATION BIOSCIENCES, INC. | 2024-06-06 | — | — | US | claimed |
| WO-2024119074-A1 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO. (US) | 2024-06-06 | — | — | WO | claimed |
| WO-2024109929-A1 | IONIZABLE LIPID AND USE THEREOF | 艾斯拓康医药科技(北京)有限公司 | 2024-05-30 | — | — | WO | claimed |
| US-20240173267-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | ONCORUS, INC. (US) | 2024-05-30 | — | — | US | claimed |
| EP-4370135-A2 | SINGLE CHAIN VARIABLE FRAGMENT (SCFV) MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | Generation Bio Co. (US) | 2024-05-22 | — | — | EP | claimed |
| WO-2024094027-A1 | BLOCKING SEQUENCE, KIT THEREOF, AND METHOD FOR USING SAME | 深圳鸿生生物科技有限公司 | 2024-05-10 | — | — | WO | claimed |
| WO-1999040789-A1 | METHODS AND COMPOUNDS FOR THE GENETIC TREATMENT OF HYPERLIPIDEMIA | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-08-19 | — | — | WO | claimed |
| WO-1999030686-A1 | CATIONIC DRUGS ENCAPSULATED IN ANIONIC LIPOSOMES | INEX PHARMACEUTICALS CORP. (CA) | 1999-06-24 | — | — | WO | claimed |
| US-5874075-A | STABILITY; HEAT RESISTANCE; ANTIAGGREGATION; NONDENATURING | AMGEN INC. (US) | 1999-02-23 | — | — | US | claimed |
| JP-2852127-B2 | — | — | 1999-01-27 | — | — | JP | claimed |
| WO-1998049350-B1 | IN VIVO USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES | — | 1999-01-07 | — | — | WO | claimed |
| WO-1998049350-A1 | IN VIVO USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-11-05 | — | — | WO | claimed |
| EP-0817614-A1 | STABLE PROTEIN:PHOSPHOLIPID COMPOSITIONS AND METHODS------------ | AMGEN INC. (US) | 1998-01-14 | — | — | EP | claimed |
| WO-1996029989-A1 | STABLE PROTEIN:PHOSPHOLIPID COMPOSITIONS AND METHODS____________ | AMGEN INC. (US) | 1996-10-03 | — | — | WO | claimed |
| EP-0671905-A1 | STABLE PROTEIN: PHOSPHOLIPID COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1995009611-A2 | STABLE PROTEIN: PHOSPHOLIPID COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1995-04-13 | — | — | WO | claimed |